PRESS RELEASE published on 01/19/2024 at 14:40, 2 years 10 months ago United Health Products Reports on FDA Application Status United Health Products (UEEC) reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze as part of its FDA application process. The reported data on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products, and the company will proceed with final drafting of the PMA documentation for submission. The press release raises awareness about the company's ongoing FDA application status and its pursuit of approval for its hemostatic products. United Health Products UEEC FDA Application Status Hemostatic Gauze Premarket Approval Application
Published on 11/20/2026 at 15:00, 8 hours 22 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 8 hours 32 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 9 hours 22 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 9 hours 52 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 9 hours 52 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 21:36, 1 hour 45 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 3 hours 56 minutes ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 4 hours 18 minutes ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:18, 5 hours 3 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary figures for FY 2025/26: Order intake above previous year, free cash flow positive; EBIT below guidance due to additional project costs in the gH2 segment
Published on 11/20/2026 at 18:34, 4 hours 47 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 5 hours 47 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 4 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 1 day 14 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing